SOD1 and amyotrophic lateral sclerosis: Antisense oligo molecules for SOD1 ALS. Given the gain of function mechanism of SOD1 ALS mutations shown in cellular and mouse models, scientific efforts have focused on developing therapeutic molecules that lower SOD1 mRNA and SOD1 protein levels.